Delivery Order SPE2DB20D3304-SPE2DB25FW8F5
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Epinephrine 0.3 mg auto-injector two-packs with a ceiling value of $1,082.90. This is a firm fixed-price delivery order with an ultimate completion date of July 22, 2025, and represents a non-set-aside, competitively awarded contract. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $2,048.11 to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Epinephrine 0.15 mg auto-injectors (two-pack units). This firm fixed-price delivery order, with an ultimate completion date of July 31, 2025, represents a competitively awarded contract with no set-aside designation. The supplies will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Epinephrine 0.15 mg auto-injectors (2-pack configuration) with a ceiling value of $1,076.82. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 6, 2025. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Epinephrine 0.3 mg auto-injector 2-packs, with a ceiling value of $1,701.70. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for ultimate completion by July 30, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a $1,874.14 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.15 mg auto-injectors (2-pack) on July 31, 2025, with an ultimate completion date of August 1, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania serves as the place of performance for this delivery order, which falls under the...
- The Defense Logistics Agency awarded a $2,273.25 delivery order to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector (2-pack) on July 18, 2025, with completion scheduled for July 21, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is located in...
- The Defense Logistics Agency (DLA) awarded a $2,665.50 delivery order to AmerisourceBergen Drug Corp for epinephrine 0.3 mg auto-injector two-packs, with a completion date of July 30, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's broader pharmaceutical supply agreements with DLA. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Epinephrine 0.3 mg auto-injector two-packs, with a contract ceiling value of $4,883.60 and an ultimate completion date of July 30, 2025. This delivery order represents a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will...
- The Defense Logistics Agency has awarded AmerisourceBergen Drug Corp a delivery order valued at $1,425.21 for the supply of Epinephrine 0.15 mg auto-injectors (2-pack) with a completion date of July 29, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under a larger contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Epinephrine 0.3 mg auto-injector (2-pack) with a ceiling value of $3,365.52 under a firm fixed price contract. This is a non-set-aside competitive award, with the place of performance located at the vendor's corporate office in Conshohocken, Pennsylvania, and an ultimate completion date of August 1, 2025. The delivery order is issued under AmerisourceBergen Drug Corp's...
- SPE2DB20D3304Indefinite Delivery Contract
- SPE2DB20D3304-SPE2DB25FW8F5Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Epinephrine 0.15 mg auto-injectors (2-pack) with a ceiling value of $1,128.69. This competitive, non-set-aside contract represents a firm fixed-price delivery order with an ultimate completion date of July 29, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, has established itself as a critical federal medical procurement vendor through its extensive portfolio of competitively awarded contracts with the Defense Logistics Agency. The company's federal contract awards encompass a wide range of pharmaceutical products and medical supplies, including specialty medications, vaccines, and medical devices across multiple therapeutic domains. All reviewed contract awards demonstrate the company's capability to meet federal procurement requirements through open competition, with pricing structures and transaction values reflecting the versatility needed to support military healthcare systems worldwide, including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 7/28/25 |